Status:
COMPLETED
Predictive Value of Cardiovascular Magnetic Resonance Related Parameters in STEMI Patients After Primary PCI for Adverse Left Ventricular Remodeling and Major Adverse Cardiovascular Events
Lead Sponsor:
Qian geng
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
This study aim to investigate the predictive value of CMR parameters: infarct size (IS), intramyocardial hemorrhage, microvascular obstruction, area at risk and CMR derived strain parameters with the ...
Detailed Description
Investigators will enroll 500 patients with STEMI after PCI who were admitted to the Chinese PLA General Hospital and other eight hospitals across China: Wuhan Asia Heart Hospital; the First People's ...
Eligibility Criteria
Inclusion
- Age 18-80 years.
- clinically diagnosed ST-segment elevation myocardial infarction.
- Intended to undergo emergency PCI.
- Voluntary enrollment and signed informed consent form.
Exclusion
- undergoing revascularization (PCI or coronary artery bypass grafting (CABG)) within 6 months;
- Pregnant and breastfeeding women;
- Contraindications of CMR: implanted cardiac defibrillator (ICD), claustrophobia, allergy to gadolinium
- Liver or kidney failure;
- Malignant tumor;
- Unconscious at present;
- systolic blood pressure (SBP) less than 80 mmHg;
- Patients with bundle branch or fascicular block, insufficient ECG data.
- Patients with other significant abnormal signs, laboratory tests and clinical disease are unsuitable for participation in the study accessed by clinicians.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04789564
Start Date
January 1 2014
End Date
December 31 2021
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853